7-107710192-T-C
Variant summary
Our verdict is Likely benign. The variant received -1 ACMG points: 1P and 2B. PP2BP4_Moderate
The NM_000441.2(SLC26A4):c.2228T>C(p.Leu743Ser) variant causes a missense change. The variant allele was found at a frequency of 0.0000138 in 1,598,972 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. L743V) has been classified as Uncertain significance.
Frequency
Consequence
NM_000441.2 missense
Scores
Clinical Significance
Conservation
Publications
- autosomal recessive nonsyndromic hearing loss 4Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, PanelApp Australia, Labcorp Genetics (formerly Invitae)
- Pendred syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae), ClinGen
- athyreosisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- thyroid hypoplasiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- hearing loss, autosomal recessiveInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -1 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| SLC26A4 | ENST00000644269.2 | c.2228T>C | p.Leu743Ser | missense_variant | Exon 19 of 21 | NM_000441.2 | ENSP00000494017.1 | |||
| SLC26A4 | ENST00000492030.2 | n.414T>C | non_coding_transcript_exon_variant | Exon 4 of 6 | 5 | |||||
| SLC26A4 | ENST00000644846.1 | n.*130T>C | non_coding_transcript_exon_variant | Exon 8 of 10 | ENSP00000494344.1 | |||||
| SLC26A4 | ENST00000644846.1 | n.*130T>C | 3_prime_UTR_variant | Exon 8 of 10 | ENSP00000494344.1 | 
Frequencies
GnomAD3 genomes  0.0000131  AC: 2AN: 152246Hom.:  0  Cov.: 32 show subpopulations 
GnomAD4 exome  AF:  0.0000138  AC: 20AN: 1446726Hom.:  0  Cov.: 27 AF XY:  0.0000167  AC XY: 12AN XY: 720544 show subpopulations 
Age Distribution
GnomAD4 genome  0.0000131  AC: 2AN: 152246Hom.:  0  Cov.: 32 AF XY:  0.0000134  AC XY: 1AN XY: 74392 show subpopulations 
Age Distribution
ClinVar
Submissions by phenotype
not provided    Uncertain:2 
This sequence change replaces leucine with serine at codon 743 of the SLC26A4 protein (p.Leu743Ser). The leucine residue is moderately conserved and there is a large physicochemical difference between leucine and serine. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals affected with SLC26A4-related conditions. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt SLC26A4 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Not observed at a significant frequency in large population cohorts (Lek et al., 2016); In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
not specified    Uncertain:1 
Variant summary: SLC26A4 c.2228T>C (p.Leu743Ser) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 251200 control chromosomes (gnomAD v2 Exomes dataset). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. To our knowledge, no occurrence of c.2228T>C in individuals affected with Pendred Syndrome and no experimental evidence demonstrating its impact on protein function have been reported. Three submitters have reported clinical-significance assessments for this variant to ClinVar after 2014. All submitters classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as uncertain significance. -
Pendred syndrome    Uncertain:1 
- -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at